Charting New Paths: Groundbreaking Advances in HPV and Typhoid Vaccination

This edition of "Getting to Zero" showcases the Sabin Vaccine Institute's momentum going into 2024, from battling HPV and cervical cancer to innovative strategies in typhoid vaccination and beyond. Dive into impactful research, collaborative projects, and groundbreaking initiatives as we highlight Sabin's relentless pursuit of a healthier future for all.

Global HPV Consortium Releases Action Plan

The Sabin-led Global HPV Consortium unveiled a three-year implementation plan that was developed with stakeholders from across the cervical cancer elimination ecosystem. The Action Plan responds to the needs and challenges that countries and communities face to make cervical cancer history. More than 340,000 women die each year from cervical cancer — a tragedy almost totally preventable with vaccines and timely screenings and treatment. More.

Restoring Immunization Post Pandemic

Responding to a gamut of basic health needs, 60 immunization projects are taking flight in 30 countries as part of the second round of a fellowship program aimed at rebuilding routine immunization coverage after COVID-19. More

Q&A: Single-Dose Typhoid Vaccine Shows Promise

A single dose of the typhoid conjugate vaccine offers protection against the disease for at least four years, says researcher Dr. Priyanka Patel and lead author of a Phase 3 study in Malawi. The vaccine is seen as a pivotal tool in the fight against extensively drug-resistant typhoid. More

Moving the Needle on Vaccinations: VARN2023 Report

The VARN2023 Conference Report includes recommendations from more than 150 presenters for increasing vaccine equity, catch-up of essential childhood immunization, and strengthening vaccination across the life course. More

Catch-up Vaccination Strategies to Match the Moment

Bamaz Karouwe Essohanam (Essohanam BAMAZI KAROUWE) and her immunization team knew COVID-19 had caused routine vaccination coverage to plummet in communities in Togo. They devised a two-pronged strategy to successfully rebuild immunization back at one center and reach those left out during the pandemic. More